Artemisinin-based combination therapy versus quinine or other combinations for treatment of uncomplicated Plasmodium falciparum malaria in the second and third trimester of pregnancy: A systematic review and meta-analysis

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Burger, Renee J ^a   van Eijk, Anna M ^b   Bussink, Milena ^a   Hill, Jenny ^b   ter Kuile, Feiko O ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Artemisinins; Malaria; Pregnancy; Quinine; Treatment

Indexed keywords

ARTEMISININ; QUININE;

ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALARIA FALCIPARUM; META ANALYSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME;

EID: 85000605832     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv170     Document Type: Article

References (32)

1. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104
2. World Health Organization. Guidelines for the Treatment of Malaria. Geneva: World Health Organization; 2006
3. World Health Organization. Guidelines for the Treatment of Malaria. 3rd ed. Geneva: World Health Organization; 2015
4. World Health Organization. World Malaria Report 2014. Geneva: World Health Organization; 2014
5. Hill J, D'Mello-Guyett L, Hoyt J, et al. Women's access and provider practices for the case management of malaria during pregnancy: a systematic review and metaanalysis PLoS Med 2014; 11:e1001688
6. AR Scientific INC. Quilaquin®, quinine sulfate, capsules USP, 324 mg. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021799s008lbl.pdf Accessed 13 June 2015
7. Kaye DK, Nshemerirwe R, Mutyaba TS, Ndeezi G. A randomized clinical trial comparing safety, clinical and parasitological response to artemetherlumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda. J Infect Dev Ctries 2008; 2:135-9
8. McGready R, Tan SO, Ashley EA, et al. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. PLoS Med 2008; 5:e253
9. Piola P, Nabasumba C, Turyakira E, et al. Efficacy and safety of artemetherlumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis 2010; 10:762-9
10. Bounyasong S. Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women. J Med Assoc Thai 2001; 84:1289-99
11. Kalilani L, Mofolo I, Chaponda M, et al. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS One 2007; 2:e1166
12. McGready R, Ashley EA, Moo E, et al. A randomized comparison of artesunateatovaquone- proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 2005; 192:846-53
13. McGready R, Brockman A, Cho T, et al. Randomized comparison of mefloquineartesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2000; 94:689-93
14. Mutabingwa TK, Muze K, Ord R, et al. Randomized trial of artesunate+ amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanaldapsone and SP for malaria in pregnancy in Tanzania. PLoS One 2009; 4: e5138
15. Sowunmi A, Oduola AM, Ogundahunsi OA, et al. Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sufadoxinepyrimethamine- resistant falciparum malaria during pregnancy. J Obstet Gynaecol 1998; 18:322-7
16. Orton LC, Omari AA. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2008; CD004912
17. Malaria in Pregnancy Consortium. Malaria in Pregnancy Library. Available at: http://library.mip-consortium.org. Accessed 2 April 2015
18. van Eijk AM, Hill J, Povall S, Reynolds A, et al. The Malaria in Pregnancy Library: a bibliometric review. Malar J 2012; 11:362
19. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6:e1000100
20. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928
21. Higgins JP, Deeks JJ. Selecting studies and collecting data. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration. Chichester, England: John Wiley & Sons Ltd, 2011:151-83
22. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007; 28:105-14
23. Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta-analyses In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration. Chichester, England: John Wiley & Sons Ltd, 2011:243-93
24. Ministry of Health Uganda, ORC Macro. Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. Calverton, MD: Ministry of Health and ORC Macro, 2006
25. Ministry of Health Uganda, ICF International, Centers for Disease Control and Prevention, US Agency for International Development, WHO Uganda Uganda AIDS Indicator Survey 2011. Kampala, Uganda: Ministry of Health Uganda, 2012
26. Higgins JP, Deeks JJ, Altman DG. Special topics in statistics. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration. Chichester, England: John Wiley & Sons Ltd, 2011: 481-524
27. World Health Organization. Antimalarial drug efficacy. Available at: http://www who.int/malaria/areas/treatment/drug_efficacy/en/. Accessed 18 January 2015
28. Schunemann HJ, Oxman AD, Higgins JP, et al. Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions: The Cochrane Collaboration. Chichester, England: John Wiley & Sons Ltd, 2011:335-57
29. Muehlenbachs A, Nabasumba C, McGready R, et al. Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial. Malar J 2012; 11:150
30. Dellicour S, Hall S, Chandramohan D, Greenwood B. The safety of artemisinins during pregnancy: a pressing question. Malar J 2007; 6:15
31. Smith Paintain L, Antwi GD, Jones C, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability. PLoS One 2011; 6:e24035
32. Thien HV, Kager PA, Sauerwein HP. Hypoglycemia in falciparum malaria: is fasting an unrecognized and insufficiently emphasized risk factor? Trends Parasitol 2006; 22:410-5